took just 52 hrs to do it :-) [R for BE/BA]

posted by ElMaestro  – Denmark, 2020-07-13 14:18 (279 d 11:38 ago) – Posting: # 21686
Views: 11,058

(edited by ElMaestro on 2020-07-13 14:31)

Hi Hötzi,


I think expressing the G matrix after this fit is a little backward;
The whole point is not to decompose V into ZGZt+R, because this design makes that decomposition pointless even when the design is otherwise relevant.
That SAS and WinNonlin and more do not have a way to make provisions for a solution outside those involving this decomposition, it merely a testament to their development capabilities than to the design itself. If you start defining the the stats model on basis of G and R rather than V then obviously you must create two variance components which are not uniquely estimable, but whose sum is. Therefore, just screw R and G, go directly for V, and present the components without in any way calling them members of G or R - they really aren't when the model is constructed my way.

The 2-trt, 3-seq, 3-per design is good, healthy and appropriate, until now it was just the statistical work on it that has been lagging. The post is an attempt at providing a solution.

Note also: The PE will be accessible via the est.b vector. You shuld be able to extract it (difference between first two effects, one good reason to do X without intercept) after the model has converged.

If you have a dataset that does not readily converge with SAS then I'd be eager to learn if it does in some flavour of my code. :-)

Pass or fail!
ElMaestro

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,509 registered users;
online 10 (0 registered, 10 guests [including 4 identified bots]).
Forum time: Monday 01:57 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5